Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing
Go back to Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing| Pfizer Inc. (NYSE: PFE) | Delayed: 27.74 +0.08 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.66 | 52 Week High | $37.39 | |||
| Open | $27.65 | 52 Week Low | $28.25 | |||
| Day High | $27.92 | P/E | 16.81 | |||
| Day Low | $27.53 | EPS | $1.65 | |||
| Volume | 28,773,170 | |||||

